Assignment Clinical Preventive Services and Health Care Coverage. Public health systems and health care work by an authority grounded both in science and in statute. For this assignment, you will...

Page | 2
Clinical Preventive Screening Services
Hemochromatosis Screening
Hemochromatosis is a serious disease condition that elevates the iron deposits in the human body to an abnormal level that predisposes the affected individuals to multiple organs failure (Porter & Rawla, 2019). The genetic testing/screening is a significant measure for racking the individuals who ca
y the high-risk genotype in the absence of clinical complications (AHRQ, 2014, p. 37). Therefore, the inclusion of this preventive service in any health insurance policy will help in administering preventive treatments in the context of minimizing the frequency of hemochromatosis in high-risk individuals. This will substantially reduce the overall health care burden related to the treatment of hemochromatosis and related como
idities. Eventually, the cost savings related to hemochromatosis treatment will not only optimize the revenue cycle management but also enhance the population health to an unprecedented level. The genetic screening for hemochromatosis does not pose any employment problem or insurance risk for the covered entities as per the Health Insurance Portability and Accountability Act of 1996 (Hall, et al., 2007). Hemochromatosis screening is a scientifically proven technique to evaluate the risk of iron overload in individuals who ca
y the risk of fe
oportin, transfe
in receptor 2, and hemojuvelin genes mutations and related autosomal recessive clinical complications (Nadakkavukaran, Gan, & Olynyk, 2012). The health insurance policymakers need to identify risk factors, including female gender, North European ethnicity, family history, mutated HFE gene duplicity, and clinical symptoms (related to weakness, fatigue, abdominal/joint pain) in the context of formulating eligibility criteria for hemochromatosis screening (MFMER, 2019).
Motor Vehicle Occupant Restraints (MVORs) Counselling
The appropriate utilization of MVORs is highly recommended to minimize the risk of MVOIs (motor vehicle occupant injuries) and related treatment expenditure (AHRQ, 2007). Furthermore, evidence reveals the potential of law enforcement campaigns, media campaigns, car seat distribution campaigns, legislative interventions, and public health strategies in terms of enhancing the use of seat belts, booster seats, and car seats among the intended consumers (AHRQ, 2014, p. 48). The scientifically proven community preventive interventions and counseling services substantially minimize the frequency of MVOIs through the extended use of child safety seat and safety belts while minimizing the prevalence of alcohol-impaired driving. The predictors of inappropriate use of MVORs include unrestrained driver, alcohol consumption, mental illnesses, and untrained children. The policy-makers have the privilege to utilize these predictors in the context of configuring an effective health insurance policy for securing the administration of MVOR-related counseling sessions to high-risk individuals. Eventually, the health insurance-based occupant restraint performance measures will offer the potential of reducing the risk of motor vehicle crash injuries for the predisposed people (Gabauer & Gabler, 2008).
Tobacco Use in Children and Adolescents (Primary Care Interventions)
Tobacco smoking frequency in children reciprocates with their family requirement and nicotine dependence of parents/caretakers (AHRQ, 2014, p. 84). Other factors that elevate the risk for tobacco use in children and adolescents include tobacco promotion campaigns, peers smoking perception, cigarettes’ accessibility, and reduced parental monitoring. Scientific evidence testifies the credibility of behavioral counseling interventions in terms of reducing the frequency of smoking addiction in adolescents and school going children. These findings substantiate the administration of tobacco use...